Graves Ophthalmopathy Recruiting Phase 3 Trials for Simvastatin (DB00641)

Also known as: Thyroid-Related Eye Disease / Graves' Ophthalmopathy (GO) / Thyroid Eye Disease / Thyroid Related Eye Disease / Graves ophthalmopathy / Graves eye disease (disorder) / Thyroid eye disease with exophthalmos (disorder) / Endocrine exophthalmos (disorder) / Thyroid eye disease (disorder) / Thyroid orbitopathy (disorder) / Dysthyroid ophthalmopathy / Graves' ophthalmopathy / Endocrine ophthalmopathy / Endocrine exophthalmos / Endocrine exophthalmos NOS (disorder) / Exophthalmos endocrine

IndicationStatusPhase
DBCOND0000969 (Graves Ophthalmopathy)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03131726Treatment of Graves┬┤Ophthalmopathy With Simvastatin (GO-DS)Treatment